Regulation of ERK5 by insulin and angiotensin-II in vascular smooth muscle cells
- 23 March 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 354 (4), 1078-1083
- https://doi.org/10.1016/j.bbrc.2007.01.102
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Dominant negative FTase (DNFTα) inhibits ERK5, MEF2C and CREB activation in adipogenesisMolecular and Cellular Endocrinology, 2005
- MicroRNA-143 Regulates Adipocyte DifferentiationJournal of Biological Chemistry, 2004
- Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endotheliumAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Activation of cyclin D1 expression by the ERK5 cascadeOncogene, 2003
- ERK5 MAPK Regulates Embryonic Angiogenesis and Acts as a Hypoxia-sensitive Repressor of Vascular Endothelial Growth Factor ExpressionJournal of Biological Chemistry, 2002
- Dominant Negative Farnesyltransferase α-Subunit Inhibits Insulin Mitogenic EffectsBiochemical and Biophysical Research Communications, 2001
- Molecular Cloning of Mouse ERK5/BMK1 Splice Variants and Characterization of ERK5 Functional DomainsPublished by Elsevier ,2001
- ERK5 and ERK2 Cooperate to Regulate NF-κB and Cell TransformationPublished by Elsevier ,2001
- Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitroBiochemical Journal, 2000
- Primary Structure of BMK1: A New Mammalian MAP KinaseBiochemical and Biophysical Research Communications, 1995